Vanda Pharmaceuticals (NASDAQ:VNDA) Given Buy Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research note published on Wednesday morning,Benzinga reports. HC Wainwright currently has a $20.00 price objective on the biopharmaceutical company’s stock. Separately, StockNews.com began coverage on shares of Vanda Pharmaceuticals in a research note on Wednesday, February 5th. They […]
HC Wainwright reissued their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research note published on Wednesday morning,Benzinga reports. HC Wainwright currently has a $20.00 price objective on the biopharmaceutical company’s stock. Separately, StockNews.com began coverage on shares of Vanda Pharmaceuticals in a research note on Wednesday, February 5th. They […]
